| |
|
Number 6 - JUNE 2005 Cartwright T, Lopez T, Vukelja SJ, Encarnacion C, Boehm KA, Asmar L. Results of a Phase II Open-Label Study of Capecitabine in Combination with Irinotecan as First-Line Treatment for Metastatic Colorectal Cancer. Clin Colorectal Cancer. 2005 May;5(1 Venook A. Critical evaluation of current treatments in metastatic colorectal cancer. Oncologist. 2005 Apr;10(4):250-61.
Elias D, Baton O, Sideris L, Boige V, Malka
D, Liberale G, Pocard M, Lasser P.
Hepatectomy plus intraoperative radiofrequency ablation and chemotherapy
to treat technically unresectable multiple colorectal liver metastases. Child PW, Yan TD, Perera DS, Morris DL. Surveillance-detected hepatic metastases from colorectal cancer had a survival advantage in seven-year follow-up. Dis Colon Rectum. 2005 Apr;48(4):744-8. Ogata Y, Matono K, Hayashi A, Takamor S, Miwa K, Sasatomi T, Ishibashi N, Shida S, Shirouzu K. Repeat pulmonary resection for isolated recurrent lung metastases yields results comparable to those afte first pulmonary resection in colorectal cancer. World J Surg. 2005 Mar;29(3):363-8. Chafai N, Chan CL, Bokey EL, Dent OF, Sinclair G, Chapuis PH. What factors influence survival in patients with unresected synchronous liver metastases after resection of colorectal cancer? Colorectal Dis. 2005 Mar;7(2):176-81. |
